Ralaniten acetate

    WARNING: This product is for research use only, not for human or veterinary use.

Hodoodo CAT#: H206494

CAS#: 1637573-04-6 (Ralaniten acetate)

Description: Ralaniten acetate, also known as EPI-506, is a potent and selective NTD inhibitor (inhibitor of the androgen receptor (AR) N-terminal domain (NTD)). In vitro and in vivo studies have shown activity against full length AR and constitutively active AR splice variants, including AR-V7 (associated with resistance to abiraterone and enzalutamide). EPI-506 is expected to be effective in mCRPC driven by both canonical and aberrant AR signaling by targeting the NTD common to full length and splice variant AR. EPI-506 is the first agent with the potential to inhibit both canonical and variant-mediated AR signaling.


Chemical Structure

img
Ralaniten acetate
CAS# 1637573-04-6 (Ralaniten acetate)

Theoretical Analysis

Hodoodo Cat#: H206494
Name: Ralaniten acetate
CAS#: 1637573-04-6 (Ralaniten acetate)
Chemical Formula: C27H33ClO8
Exact Mass: 520.19
Molecular Weight: 521.003
Elemental Analysis: C, 62.24; H, 6.38; Cl, 6.80; O, 24.57

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Related CAS #: 1203490-23-6 (Ralaniten)   1637573-04-6 (Ralaniten acetate),  

Synonym: EPI-506; EPI 506; EPI506; Ralaniten acetate

IUPAC/Chemical Name: (S)-3-(4-(2-(4-((S)-2-acetoxy-3-chloropropoxy)phenyl)propan-2-yl)phenoxy)propane-1,2-diyl diacetate

InChi Key: HGHVYYKTOXUQNT-CLJLJLNGSA-N

InChi Code: InChI=1S/C27H33ClO8/c1-18(29)32-16-26(36-20(3)31)17-34-24-12-8-22(9-13-24)27(4,5)21-6-10-23(11-7-21)33-15-25(14-28)35-19(2)30/h6-13,25-26H,14-17H2,1-5H3/t25-,26-/m1/s1

SMILES Code: CC(C1=CC=C(OC[C@H](OC(C)=O)COC(C)=O)C=C1)(C2=CC=C(OC[C@H](OC(C)=O)CCl)C=C2)C

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO, not in water

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 521.00 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Maughan BL, Antonarakis ES. Clinical Relevance of Androgen Receptor Splice
Variants in Castration-Resistant Prostate Cancer. Curr Treat Options Oncol. 2015
Dec;16(12):57. doi: 10.1007/s11864-015-0375-z. PubMed PMID: 26537882.